Lataa...
3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors
Dengue is a severe mosquito-borne viral infection causing half a million deaths annually. Dengue virus NS2B/NS3 protease is a validated target for anti-dengue drug design. A series of hitherto unreported 3,5-bis(arylidene)-4-piperidones analogues 4a—4j were synthesized and screened in silico against...
Tallennettuna:
| Julkaisussa: | Acta Pharm Sin B |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5518655/ https://ncbi.nlm.nih.gov/pubmed/28752033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2017.04.009 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|